Ellutia is presenting its nitrosamine testing solution for pharmaceuticals using its 800 Series Thermal Energy Analyser with Chemical Stripping System
The new kit promises enhanced performance and flexibility to power cancer and genetics research
New Gallant high-voltage devices offer patients and their doctors a smartphone app and Bluetooth connectivity
Positive in vivo efficacy and pharmacokinetic data shows AVA04-VbP drug conjugate out-performed Bavencio immunotherapy
Free yourself from the time-consuming burden of picking sample tubes and embrace a fresh, new perspective
The change of name is a contractual requirement of its divestment from TTP Group in 2018 with the backing of technology-focused investment firm Battery Ventures
The antibody is being trialed for use in the treatment of B cell Acute Lymphoblastic Leukemia
PWC-Colorcon-TruTag technology coalition prove out the mass digitalization of pharma pills
Harvard, MIT, and various teaching hospitals team up with industry partners to launch new center for regenerative therapies
The Ziath range of CryzoTraq™ 2D-barcoded tubes aims to set a new standard for cryogenic storage of biological specimens at temperatures as low as -196°C
Clinical trial will evaluate the safety and immunogenicity of Entervax™
Distinguished speaker Dr. Bruce Levine addresses some of the current healthcare challenges that impact the development of new therapies
Proximity will facilitate local and international sponsor access to Kayentis’ eCOA services for mid- to later-stage clinical trials
LG Chem selects second and third drug targets following rapid progress in first program
Zelluna Immunotherapy presented data on its lead compound ZI-H04 at the Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Promega enters global collaboration with Merck to develop Microsatellite Instability (MSI) companion diagnostic for use with KEYTRUDA®
Lead allosteric PLK1 inhibitor to progress through preclinical and IND enabling studies
Thermo Fisher Scientific's forum focuses on strategies to expedite biotherapeutic development and commercialization
New technique could enable assembly of circuit boards and displays with more minute components
New collaboration to focus on developing potent Affimer-drug conjugates
Incorporation of AI technologies highlights the most accurate compound predictions to enable effective project decision-making
Designed specifically for smaller biobanks the BB package simplifies sample integrity, tracking and audit trail.
